UCLouvain
" Production of SARS-Cov-2 glycoproteins in glyco-engineered plant suspension cells to obtain homogenous and predefined N-glycosylation profiles, characterize their binding and/or produce vaccine. "
Funding: Own funding and WALInnov
Contact: francois.chaumont@uclouvain.be catherine.navarre@uclouvain.be UCLouvain/LIBST